Becker Capital Management Inc Astrazeneca PLC Transaction History
Becker Capital Management Inc
- $2.95 Billion
- Q1 2025
A detailed history of Becker Capital Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Becker Capital Management Inc holds 381,117 shares of AZN stock, worth $28 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
381,117
Previous 378,997
0.56%
Holding current value
$28 Million
Previous $24.8 Million
12.81%
% of portfolio
0.95%
Previous 0.83%
Shares
32 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
508MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.2 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.03 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.62 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.34 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.3 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...